Literature DB >> 21667321

Multimarker strategies for detecting NASH and NASH-related fibrosis: promises and caveats.

Yusuf Yilmaz, Ramazan Kurt, Fatih Eren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21667321     DOI： 10.1007/s11695-011-0464-4

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   4.129


× No keyword cloud information.
  4 in total

1.  A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis.

Authors:  Zobair M Younossi; Sandra Page; Nila Rafiq; Aybike Birerdinc; Maria Stepanova; Noreen Hossain; Arian Afendy; Zahra Younoszai; Zachary Goodman; Ancha Baranova
Journal:  Obes Surg       Date:  2011-04       Impact factor: 4.129

Review 2.  Toward a biochemical diagnosis of NASH: insights from pathophysiology for distinguishing simple steatosis from steatohepatitis.

Authors:  Y Yilmaz; E Ulukaya
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

3.  Clinical evaluation of serum tissue inhibitor of metalloproteinases-1 levels in patients with liver diseases.

Authors:  D A Muzzillo; M Imoto; Y Fukuda; Y Koyama; S Saga; Y Nagai; T Hayakawa
Journal:  J Gastroenterol Hepatol       Date:  1993 Sep-Oct       Impact factor: 4.029

Review 4.  Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis.

Authors:  Yusuf Yilmaz; Alla Eldeen Kedrah; Osman Ozdogan
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.